These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

13361 related articles for article (PubMed ID: 101414)

  • 1. Enhancing effect of coenzyme, Q10 on immunorestoration with Mycobacterium bovis BCG in tumor-bearing mice.
    Kawase I; Niitani H; Saijo N; Sasaki H; Morita T
    Gan; 1978 Aug; 69(4):493-7. PubMed ID: 101414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cell-wall skeleton of Mycobacterium bovis BCG on cell-mediated cytotoxicity in tumor-bearing mice.
    Taniyama T; Azuma I; Aladin AA; Yamamura Y
    Gan; 1975 Dec; 66(6):705-9. PubMed ID: 817955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant activity of mycobacterial fractions. III. Adjuvant effect of cell wall of Mycobacterium bovis BCG on cell-mediated cytotoxicity in mice.
    Taniyama T; Azuma I; Yamamura Y
    Jpn J Microbiol; 1975 Aug; 19(4):255-64. PubMed ID: 811834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined effect of BCG and coenzyme Q10 on ATP-ase activity and coenzyme Q content in spleen lymphocytes of tumor-bearing rats.
    Niitani H; Kawase I; Taniguchi T; Saijo N; Irimajiri N
    Gan; 1979 Jun; 70(3):315-22. PubMed ID: 157309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy of cancer with cell wall skeleton of Myocabacterium bovis-Bacillus Calmette-Guérin: experimental and clinical results.
    Yamamura Y; Azuma I; Taniyama T; Sugimura K; Hirao F; Tokuzen R; Okabe M; Nakahara W; Yasumoto K; Ohta M
    Ann N Y Acad Sci; 1976; 277(00):209-27. PubMed ID: 826205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCG immunopotentiation of an antitumor response: evidence for a cell-mediated mechanism.
    Hawrylko E
    J Natl Cancer Inst; 1975 Aug; 55(2):413-23. PubMed ID: 808641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunopotentiation with BCG: dimensions of a specific antitumor response.
    Hawrylko E
    J Natl Cancer Inst; 1975 May; 54(5):1189-97. PubMed ID: 805254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophages elicited with heat-killed bacillus Calomette-Guérin protect C57BL/6J mice against a syngeneic melanoma.
    Freedman VH; Calvelli TA; Silagi S; Silverstein SC
    J Exp Med; 1980 Sep; 152(3):657-73. PubMed ID: 6997425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of in vitro cell-mediated reactivity against syngeneic tumor cells by various lymphoid cell populations from Bacillus Calmette-Guérin-tumor-cured, tumor-sensitized, tumor-bearing, and normal inbred guinea pigs.
    Fidler IJ; Kataoka T; Hanna MG
    Cancer Res; 1976 Dec; 36(12):4459-66. PubMed ID: 187324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific and nonspecific antitumor immunity. III. Specific T lymphocyte-mediated cytolysis of P815 mastocytoma and SL2 lymphoma by draining lymph node cells from syngeneic tumor-bearing DBA/2J mice.
    Germain RN; Williams RM; Benacerraf B
    Am J Pathol; 1976 Dec; 85(3):661-74. PubMed ID: 826167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro induction of cytotoxicity against syngeneic mastocytoma and its suppression by spleen and thymus cells from tumor-bearing mice.
    Takei F; Levy JG; Kilburn DG
    J Immunol; 1976 Feb; 116(2):288-93. PubMed ID: 814160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of suppressor cells in mice bearing syngeneic mastocytoma.
    Takei F; Levy JG; Kilburn DG
    J Immunol; 1977 Feb; 118(2):412-7. PubMed ID: 65423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of lipopolysaccharide in tumor-bearing mice pretreated with BCG.
    Sato H; Ito M; Abe T; Kumano N; Motomiya M; Konno K
    Tohoku J Exp Med; 1986 Dec; 150(4):391-9. PubMed ID: 3105117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of cell-mediated alloimmunity by BCG. II. Induction of specific, nonadherent, non-T-killer cells by BCG and alloantigen.
    Murahata RI; Mitchell MS
    J Natl Cancer Inst; 1982 Sep; 69(3):613-8. PubMed ID: 6810008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage function in tumor-bearing mice: tumoricidal and chemotactic responses of macrophages activated by infection with Mycobacterium bovis, strain BCG.
    Meltzer MS; Stevenson MM
    J Immunol; 1977 Jun; 118(6):2176-81. PubMed ID: 325142
    [No Abstract]   [Full Text] [Related]  

  • 16. Negative and positive immunobiological responses in mice pretreated with Bacillus Calmette-Guérin cell wall.
    Mizushima Y; Wepsic HT; Yamamura Y; DeSilva MA; Janns G; Larson CH
    Cancer Res; 1984 Jan; 44(1):20-4. PubMed ID: 6228292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced tumorigenicity of B16-F10 mouse melanoma cells transfected with mycobacterial antigen 85A.
    Tarrant JP; Walsh MJ; Blanchard MC; Lee TD; Hoskin DW; Giacomantonio CA
    Int J Oncol; 2004 Dec; 25(6):1693-9. PubMed ID: 15547707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of tumor cell resistance to syngeneic cell-mediated cytotoxicity during growth of ascitic mastocytoma P815Y.
    Biddison WE; Palmer JC
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):329-33. PubMed ID: 402006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the mode of action of BCG.
    Mitchell MS; Kirkpatrick D; Mokyr MB; Gery I
    Nat New Biol; 1973 Jun; 243(128):216-8. PubMed ID: 4197570
    [No Abstract]   [Full Text] [Related]  

  • 20. Specific and nonspecific antitumor immunity. II. Macrophage-mediated nonspecific effector activity induced by BCG and similar agents.
    Germain RN; Williams RM; Benacerraf B
    J Natl Cancer Inst; 1975 Mar; 54(3):709-20. PubMed ID: 1091741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 669.